Krishna Institute of Medical Sciences Share Pledge
Promoters pledged 2,80,08,979 equity shares (6.66%) to Catalyst Trusteeship as debenture trustee. The pledge secures existing debenture obligations with no new capital involved.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements with these filters
Promoters pledged 2,80,08,979 equity shares (6.66%) to Catalyst Trusteeship as debenture trustee. The pledge secures existing debenture obligations with no new capital involved.
Krishna Institute of Medical Sciences Ltd entered an Operations and Management Agreement with Sarvottam Health Care Pvt Ltd for 5+5 years to manage their operations.
KIMS Hospitals held its 24th Annual General Meeting on August 27, 2026. The meeting discussed financial statements and various ordinary and special business items.
KIMS has clarified that the news report claiming a $52 million acquisition of Renova Hospitals is false. The company confirms no such discussions or agreements exist.
KIMS entered into an Operations and Management Agreement and Call Option Agreement with Aurevia Hospitals to manage Arete Hospitals for an initial five-year term.
KIMS has entered into an Operations and Management Agreement to manage Arete Hospitals, Hyderabad, for an initial 5-year term. It also secured an acquisition call option.
KIMS allotted 77,02,182 warrants on a preferential basis to promoters. The company received Rs. 149.99999 Crore as 25% subscription money for these warrants.
KIMS Hospitals has received in-principle approval from BSE and NSE to issue 77,02,182 warrants to promoters on a preferential basis.
KIMS Hospitals submitted its Integrated Annual Report for FY 2025-26 to the stock exchanges. The document is available on the company's website for shareholders.
Krishna Institute of Medical Sciences Limited will hold its 24th Annual General Meeting on August 27, 2026, via video conferencing.
KIMS delivered strong EBITDA margins despite lower ARPOB compared to peers, driven by lean operational efficiency and high patient volumes.
Krishna Institute of Medical Sciences Limited filed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming no material deviations in QIP proceeds utilization.
KIMS reported strong Q1 FY27 results with consolidated operating revenue growth of 35.3% YoY and 9.8% QoQ, driven by expansion and higher occupancy in core clusters.
Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,180 Cr (+35.3% YoY) and net profit of ₹37.4 Cr (-56.0% YoY) for Q1 FY27.
Krishna Institute of Medical Sciences has scheduled a board meeting for August 03, 2026. The board will consider and approve unaudited financial results for the first quarter.
Krishna Institute of Medical Sciences Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing details the distribution of equity shares among various stakeholders.